Levels of Visfatin/NAMPT in Human Milk

Levels of Visfatin/NAMPT in Human Milk.VISFAMILK

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06487286

Acronym

VISFAMILK

Enrollment

Registered

2024-07-05

Start date

2024-10-24

Completion date

2025-04-23

Last updated

2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth Weight, Visfatin Levels in Maternal Milk Samples

Keywords

Newborns, Visfatin, Breastfeeding

Brief summary

Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.

Detailed description

The aim of the study is to analyse a retrospective cohort of well characterized mothers in their post-partum period, and to measure Visfatin levels through collection of maternal milk samples. They will be collected in three different moments after the birth (48 hours, 7 days and 30 days) and Visfatin levels will be analysed through an ELISA kit Adipogen. In parallel, the levels of Visfatin will be evaluated in the maternal plasma/serum collected after 1-2 days postpartum. Lastly, correlations between Visfatin levels and biological/clinical features of mothers and newborns will be explored.

Interventions

OTHERobservational study

observational study

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Healthy male and female infants born after 37 weeks' gestation who do not have conditions related to congenital abnormalities * Maternal hospitalization * Acquisition of the informed consent form signed by the patient

Exclusion criteria

* Refusal of the patient to participate in the study * Presence of hypogalactia or agalactia in the patient

Design outcomes

Primary

Measure	Time frame	Description
Visfatin levels	48 hours, 7 days and 30 days	Visfatin levels in maternal milk samples

Secondary

Measure	Time frame	Description
values of Visfatin	6 months	correlate the values of Visfatin to different demographic and clinical characteristics of the lactating mothers

Countries

Italy

Contacts

Primary ContactPaolo Manzoni, Professor

paolo.manzoni@aslbi.piemonte.it+39 01515156906

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026